Eric Lefkofsky, a well-known entrepreneur and the Chairman of Groupon, is making significant changes in cancer treatments with genomic data. His firm, Tempus, is on a revolutionary move with a mission to capture genomic and transcriptomic sequencing in its environment to make simpler and easier access to physicians to make it useful for them to understand the behavior of each patient’s tumor better. It was earlier found that the doctors were struggling to get the data of cancer patients’ treatment history and their response to various medication with respect to the type of cancer and their gene structure. It has created a problem in advising proper treatment regime to the patients that can be more effective.
Lefkofsky identified it as a severe issue, and he thought if there a proper genome sequencing and clinical data made available to the doctors, it would help them to instruct accurate treatment regime and can also be helpful in targeted therapies. With that mission, Lefkofsky left Groupon as CEO and co-founded Tempus in 2016. Tempus is a technology firm which is on a mission to create the largest library of clinical and molecular data. It also created an operating system that makes the data instantly available. Under Lefkofsky, the firm follows an approach of sequencing, analytics, reporting, and validation. The Tempus campus has a state-of-the-art lab which uses data science and technology. The highly-robotic lab is enabled to give next-generation sequencing of more than 50,000 patients annually. The sequencing includes germline, RNA-seq capture, and all other types of sequencing, and it completes within the 2-3 weeks after receiving the sample.
Lefkofsky also has deep interests in philanthropy, and he formed a charitable trust called Lefkofsky familly Foundation in 2006. It supports various educational, charitable, and scientific causes around the world with a focus on children. In 2013, he and his wife, Elizabeth, registered with The Giving Pledge, a campaign that connects wealthy people to contribute the significant amount of their wealth to philanthropic causes. Lefkofsky is also on the boards of The Art Institute of Chicago, The Museum of Science and Industry, World Business Chicago, Children’s Memorial Hospital – Chicago, and Steppenwolf Theatre Company.